Skip to main content
Guttmacher Institute

Search

  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Safe Abortion Calculator
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases
  • Videos

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
Guttmacher Institute
Donate

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Safe Abortion Calculator
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases
  • Videos

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact
Video
August 26, 2026

Fighting Misinformation About Abortion in the US, Part 2

Anti-abortion policymakers in the US are using junk science to undermine access to medication abortion. 

In Part 2 of our series, The Facts You Need to Know to Fight False Claims About Abortion, Guttmacher US communications manager Isabel Guarnieri breaks down the data on medication abortion and explains how attacks on access are rooted in political ideology—not evidence.

Video

Transcript:

Welcome back to our series, We covered the basics in part one, and in part two, we'll discuss the safety of medication abortion.

You will hear us say it again and again, medication abortion is safe, effective and essential. Because it is. Decades of scientific evidence from the US and around the world have clearly established mifepristone's strong safety profile.

Other medication abortion regimens, like those that use misoprostol alone, also have long-established safety records. Moreover, evidence has proven that telehealth provision of medication abortion, where patients receive abortion pills by mail after virtually consulting with a clinician, is also safe and effective.

All attacks on medication abortion and its provision through telehealth are based in political ideology, not evidence, and definitely not with patients' interest in mind. 65% of abortions in the United States were medication abortions in 2023.

Restrictions that run counter to robust evidence jeopardize the reproductive freedom and health of hundreds of thousands of people.

Don't fall for anti-abortion rhetoric. Share the facts widely and check back soon for the next part in our series.

Share

Guttmacher Institute

Center facts. Shape policy.
Advance sexual and reproductive rights.®

Donate Now
Newsletter Signup  Contact Us 
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Footer

  • Privacy Policy
  • Accessibility Statement
© 2026 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.